Company Performance Metrics
Ottoman Pharma is a veterinary bio-pharmaceutical manufacturer focused on poultry health. The company develops, produces, and distributes inactivated poultry vaccines targeting avian influenza, Newcastle disease, infectious bronchitis, egg drop syndrome, hydropericardium syndrome, and related viral conditions. Its vaccine range includes branded
products such as OTTO FLU VAC, OTTO FLUPLUS VAC, OTTO FIGHT FLU VAC, OTTO ND VAC, OTTO BRONCHITIS VAC, OTTO EDS VAC, AVIAN FLU COMBO, AVIAN VAC H9, and BIRD FLU VAC. Ottoman Pharma operates dedicated production, quality control, and quality assurance units and holds a manufacturing license from the Drug Regulatory Authority of Pakistan. The company also runs diagnostics services using RT-PCR and conventional PCR platforms to detect poultry pathogens and support vaccine matching to circulating field strains. Through research farms and collaboration with universities, it supports applied research and vaccine evaluation for commercial poultry producers.
